Skip to content

To Evaluate the Paediatric Analgesia Slide

To Evaluate the Paediatric Analgesia Slide, a New Device Developed to Assist Parents in Administering Paracetamol to Children at Home

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00765609
Enrollment
140
Registered
2008-10-03
Start date
2008-12-31
Completion date
2009-03-31
Last updated
2008-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Paediatric, Analgesic, Prescribing, Parents

Brief summary

The Paediatric Analgesia Slide is a device developed for parents. Its development follows research into the Paediatric Analgesia Wheel, a device intended for use by hospital doctors. Previous research has shown the benefit of using aids such as the Paediatric Analgesia Wheel when simulating prescribing to children in hospital. At present, it is unknown whether this concept can be extended to use by parents when administering paracetamol to their children at home.

Detailed description

Prescribing and administering drugs to children is difficult for both healthcare professionals and parents. The process is often performed poorly with under-dosing and over-dosing a major problem with sometimes fatal consequences. The British National Formulary for Children (BNFC), introduced in 2005, has given hospital and community prescribers with a valuable reference text. However, the comprehensive prescribing information presented in the BNFC and in the drug Summary of Product Characteristics is simplified in the Patient Information Leaflet (PIL) for interpretation by parents. When the PIL is analysed, it becomes apparent that the age-range regimens presented may result in under and over-dosing with large differences in the daily dose received by children depending on their age and weight. The Paediatric Analgesia Slide is a simple device presenting pre-calculated volume (and therefore dose) information for parents. It allows for age/weight specific doses to be given thus minimising the risk of under and over-dosing. It also addresses the deficiency of the prescribing information in the PIL related to over and under-weight children.

Interventions

None listed

Sponsors

County Durham and Darlington NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any parent accompanying their child who is aged between 1 and 13 years old who is attending a hospital in County Durham and Darlington Acute Hospitals NHS Trust

Exclusion criteria

* Those who have professional knowledge of prescribing or dispensing medicine (e.g. as a doctor, nurse or pharmacist); * Those who already have been given advice on the correct dose of paracetamol for their child as part of the current hospital episode; * Those who's child is under 1 year or over 13 years old and; * Those who have participated in this research before.

Design outcomes

Primary

MeasureTime frame
Comparison of prescription accuracy using the information distributed with over-the-counter medication with the new deviceat data analysis

Secondary

MeasureTime frame
Ability of parents to interpret the prescribing information related to minimum dosage interval and maximum dosage frequencyat data analysis
To assess whether parents can accurately draw up the volume that they have stated in the primary objectiveat data analysis

Countries

United Kingdom

Contacts

Primary ContactRichard C Hixson, BM BS, FRCA
Richard.Hixson@cddft.nhs.uk0044 1325 743327

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026